Swindells S, Andrade-Villanueva JF, Richmond GJ, et al. Long-acting cabotegravir + rilpivirine as maintenance therapy: ATLAS week 48 results. CROI 2019, abstract 139.
SOF/VEL/VOX effectief en veilig bij hepatitis C na falen op DAA’s
mrt 2020 | Hepatitis